preclinical related Press Releases

NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains H1N1 Virus-like

... Read more...

ReNeuron announces positive pre-clinical data with lead stem cell line in peripheral arterial disease 06/04/09 Guildford, UK, 6 April 2009: ReNeuron Group plc (LSE: RENE.L) today announces positive

... Read more...

Alkermes Presents Positive Preclinical Data on Novel, Proprietary Molecule Designed to Improve Outcomes for Patients Taking Opioid Analgesics Second New Program Disclosed During Calendar 2008

... Read more...

Ardea Biosciences Presents Preclinical Data on its Lead MEK Inhibitor, RDEA119, Demonstrating Synergy with Other Anti-Cancer Agents in Multiple Tumor Types October 24, 2008--SAN DIEGO--(BUSINESS

... Read more...

Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies SAN FRANCISCO, Oct. 24 /PRNewswire/ -- Vaxart Inc., a biotechnology company focused on the development of oral... Read more...

Hollis-Eden Pharmaceuticals Presents HE3235 Update at ASCO Breast Cancer Symposium Preclinical Data Show Lasting Anti-Tumor Effect of Novel Drug Candidate SAN DIEGO -- Hollis-Eden Pharmaceuticals,... Read more...

FermaVir Announces Positive Data from Recent Preclinical Studies of FV-100 FermaVir Pharmaceuticals, Inc. today announced positive results from preclinical studies evaluating FV-100, a highly potent,

... Read more...